Experienced industry experts and investment specialists.

The Swiss investment company Vitruvia Medical AG invests in companies from the healthcare industry with a focus on medical devices.

Vitruvia’s management consists of a team of highly specialized industry experts who have been working together for decades and have already successfully implemented multiple investment projects. The aim has always been to combine innovative and sustainable solutions with economic success.

Bertschin-Vitruvia-Web-800x800px

Markus A. Bertschin

PRESIDENT OF THE BOARD OF DIRECTORS


Markus A. Bertschin has many years of financial and management experience through his work for international banks, most recently as Managing Director of Deutsche Bank (Schweiz) AG. Since 2012, he has been concentrating on starting up various companies focusing on innovative production methods.

Dr.-Siever-Vitruvia_Web-800x800px

Dr. Robert P. Sieber

BOARD OF DIRECTORS


Dr. Sieber is an orthodontics specialist in Switzerland and the USA, who, in 1994, opened what has become the largest orthodontics practice in the Basel region. From 1995 through 2010 he served as President of the Specialization Commission of the Swiss orthodontics association (Schweizerische Gesellschaft für Kieferorthopädie, SGK) and has been an external instructor at the University of Basel since 2016.

Claus Wiest Vitruvia

Claus Wiest

MANAGING DIRECTOR


Claus Wiest has been active in the distribution of medical instruments both nationally and internationally since 1998. In 2010, he jointly founded LT technologies GmbH & Co.KG, a successful company for the maintenance and repair of surgical instruments and optics, which he has since led as managing director.

History I Milestones on the road to market leadership

Development of processes for reprocessing instruments used in robot-assisted surgery, founding of Vitruvia AG (Switzerland) as financial holding

Founding of Vitruvia GmbH (Germany) as operating company and acquisition of steriPartner GmbH with comprehensive expertise in the reprocessing of surgical instruments

Extension of Vitruvia GmbH in the areas of process development, validation, QM, IT and sales

Acquisition of the property and start of planning and construction activity for the first European Circular Clinic Supply Center for robotic instruments

Grant of funding by the Federal State of Saxony-Anhalt and the European Union and support for hospitals in the fight against the coronavirus pandemic through the supply of personal protective equipment

Acquisition of LT technologies GmbH & Co. KG as a specialist for the cross-manufacturer repair of endoscopic and surgical instruments

Opening of the first European Circular Clinic Supply Center for robotic instruments in Schönebeck/ Elbe and start of the operative business of reprocessing instruments for robot-assisted surgery

Listing of Vitruvia Medical AG for trading on the Munich Stock Exchange

Renaming of steriPartner GmbH in Vitruvia Consulting GmbH – Institute of Quality Assurance in Medical Device Reprocessing

Certification of the QM system to DIN EN ISO 13485:2016 (KRINKO) for the reprocessing of all surgical instruments, including those classed at the highest “critical C” risk level